BOK Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.4M Sell
51,543
-787
-2% -$798K 0.72% 29
2025
Q4
$56.2M Sell
52,330
-3,895
-7% -$3.72M 0.86% 23
2025
Q3
$42.9M Sell
56,225
-224
-0.4% -$167K 0.65% 30
2025
Q2
$44M Sell
56,449
-610
-1% -$474K 0.71% 29
2025
Q1
$47.1M Sell
57,059
-278
-0.5% -$231K 0.83% 23
2024
Q4
$45.9M Sell
57,337
-796
-1% -$659K 0.77% 26
2024
Q3
$51.5M Buy
58,133
+1,555
+3% +$1.4M 0.91% 22
2024
Q2
$51.2M Sell
56,578
-500
-0.9% -$400K 0.92% 21
2024
Q1
$43.4M Sell
57,078
-382
-0.7% -$272K 0.79% 25
2023
Q4
$33.5M Sell
57,460
-2,475
-4% -$1.44M 0.66% 35
2023
Q3
$33.2M Sell
59,935
-1,137
-2% -$586K 0.73% 31
2023
Q2
$28.6M Sell
61,072
-3,601
-6% -$1.51M 0.58% 39
2023
Q1
$22.2M Sell
64,673
-3,747
-5% -$1.26M 0.46% 46
2022
Q4
$25M Sell
68,420
-3,048
-4% -$1.08M 0.46% 50
2022
Q3
$23.1M Buy
71,468
+21,362
+43% +$6.77M 0.47% 50
2022
Q2
$16.2M Sell
50,106
-37
-0.1% -$11.1K 0.31% 75
2022
Q1
$14.4M Sell
50,143
-3,968
-7% -$1.02M 0.24% 93
2021
Q4
$14.9M Sell
54,111
-2,166
-4% -$549K 0.23% 97
2021
Q3
$13M Buy
+56,277
New +$13.9M 0.22% 100
2021
Q1
$14.3M Buy
76,424
+3,811
+5% +$745K 0.26% 91
2020
Q4
$12.3M Sell
72,613
-538
-0.7% -$80.3K 0.23% 98
2020
Q3
$10.8M Buy
73,151
+23,425
+47% +$3.63M 0.24% 97
2020
Q2
$8.16M Buy
49,726
+8,112
+19% +$1.25M 0.19% 118
2020
Q1
$5.77M Buy
41,614
+6,022
+17% +$827K 0.17% 131
2019
Q4
$4.68M Sell
35,592
-7,388
-17% -$856K 0.11% 201
2019
Q3
$4.81M Sell
42,980
-11,862
-22% -$1.32M 0.12% 196
2019
Q2
$6.08M Sell
54,842
-24,735
-31% -$2.91M 0.15% 169
2019
Q1
$10.3M Buy
79,577
+1,933
+2% +$235K 0.25% 94
2018
Q4
$8.98M Sell
77,644
-4,194
-5% -$468K 0.26% 91
2018
Q3
$8.78M Sell
81,838
-11,160
-12% -$1.12M 0.22% 108
2018
Q2
$7.94M Buy
92,998
+18
+0% +$1.48K 0.21% 114
2018
Q1
$7.19M Buy
92,980
+2,328
+3% +$187K 0.2% 126
2017
Q4
$7.66M Buy
90,652
+2,513
+3% +$214K 0.21% 116
2017
Q3
$7.54M Buy
88,139
+10,843
+14% +$889K 0.22% 111
2017
Q2
$6.36M Buy
77,296
+9,054
+13% +$739K 0.2% 117
2017
Q1
$5.74M Buy
68,242
+19,704
+41% +$1.58M 0.18% 137
2016
Q4
$3.57M Buy
48,538
+1,466
+3% +$109K 0.12% 202
2016
Q3
$3.78M Buy
47,072
+14,679
+45% +$1.17M 0.13% 188
2016
Q2
$2.55M Sell
32,393
-10,465
-24% -$788K 0.09% 255
2016
Q1
$3.09M Sell
42,858
-1,472
-3% -$111K 0.11% 213
2015
Q4
$3.73M Buy
44,330
+2,096
+5% +$174K 0.14% 183
2015
Q3
$3.54M Sell
42,234
-12,527
-23% -$1.06M 0.13% 187
2015
Q2
$4.57M Sell
54,761
-3,238
-6% -$247K 0.16% 155
2015
Q1
$4.21M Buy
57,999
+3,631
+7% +$259K 0.14% 171
2014
Q4
$3.75M Sell
54,368
-15,648
-22% -$1.06M 0.13% 177
2014
Q3
$4.54M Buy
70,016
+5,910
+9% +$374K 0.15% 150
2014
Q2
$3.99M Sell
64,106
-64,732
-50% -$3.86M 0.13% 181
2014
Q1
$7.58M Sell
128,838
-5,793
-4% -$323K 0.25% 91
2013
Q4
$6.87M Sell
134,631
-129,129
-49% -$6.47M 0.23% 100
2013
Q3
$13.3M Buy
263,760
+39,381
+18% +$2.06M 0.48% 42
2013
Q2
$11M Buy
+224,379
New +$12.2M 0.42% 53

Other funds holding LLY

BOK Financial's LLY Position: Q1 2026 in Review

BOK Financial reduced its Eli Lilly (LLY) stake by 1.5% in Q1 2026, selling an estimated $798K and leaving 51,543 shares worth $47.4M. The position accounts for 0.72% of the portfolio, ranked #29.

BOK Financial first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. The position peaked at $56.2M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • BOK Financial held 51,543 shares of Eli Lilly worth $47.4M as of Q1 2026.
  • BOK Financial sold 787 Eli Lilly shares in Q1 2026, an estimated $798K.
  • Eli Lilly made up 0.72% of BOK Financial's portfolio in Q1 2026, its #29 holding.
  • BOK Financial first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
  • BOK Financial's Eli Lilly position peaked at $56.2M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on BOK Financial's 13F filing for Q1 2026, filed 8 May 2026.